THA increases action potential duration of central histamine neurons in vitro
- 1 October 1988
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 155 (3) , 265-270
- https://doi.org/10.1016/0014-2999(88)90512-2
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Alzheimer's disease: Neurofibrillary tangles in nuclei that project to the cerebral cortexPublished by Elsevier ,2003
- Further analysis of the neuropharmacological profile of 9-amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's diseaseLife Sciences, 1988
- Pharmacologically distinct actions of serotonin on single pyramidal neurones of the rat hippocampus recorded in vitro.The Journal of Physiology, 1987
- 9-Amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease, inhibits acetylcholinesterase activity and slow outward K+ currentEuropean Journal of Pharmacology, 1987
- Differential modulation of three separate K-conductances in hippocampal CA1 neurons by serotoninNature, 1987
- Alzheimer's Disease: A Disorder of Cortical Cholinergic InnervationScience, 1983
- A transient outward current in a mammalian central neurone blocked by 4-aminopyridineNature, 1982
- Intracellular recordings from serotonergic dorsal raphe neurons: pacemaker potentials and the effects of LSDBrain Research, 1982
- Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementiaNeurology, 1982
- Muscarinic suppression of a novel voltage-sensitive K+ current in a vertebrate neuroneNature, 1980